Vaishampayan, U.N
153  Ergebnisse:
Personensuche X
?
 
?
 
?
7

Activity of the FGFR1–3 inhibitor infigratinib in patients ..:

De Giorgi, U. ; Pal, S.K. ; Rosenberg, J.E....
European Urology Supplements.  18 (2019)  11 - p. e3405-e3406 , 2019
 
?
9

A single-institution experience with concurrent capecitabin..:

Vaishampayan, U.N ; Ben-Josef, E ; Philip, P.A...
International Journal of Radiation Oncology*Biology*Physics.  53 (2002)  3 - p. 675-679 , 2002
 
?
10

Radiosensitization with capecitabine in gastrointestinal ma..:

Ben-Josef, E. ; Vaishampayan, U.N. ; Vaitkevicius, V....
International Journal of Radiation Oncology*Biology*Physics.  51 (2001)  3 - p. 260 , 2001
 
?
12

Nomogram-based risk prediction of local and distant relapse..:

Raggi, D. ; Pond, G. ; Giannatempo, P....
European Urology Supplements.  17 (2018)  2 - p. e519-e520 , 2018
 
?
13

Pattern of relapse after perioperative chemotherapy and rad..:

Necchi, A. ; Pond, G. ; Plimack, E....
European Urology Supplements.  16 (2017)  10 - p. e2794-e2795 , 2017
 
?
14

2607 Predicting venous thromboembolism (VTE) in metastatic ..:

Ramos, J. ; Casey, M. ; Bamias, A....
European Journal of Cancer.  51 (2015)  - p. S514 , 2015
 
?
15

7 Characterizing the impact of lymph node metastases on sur..:

Kröger, N. ; Pantuck, A. ; Wells, C....
European Urology Supplements.  14 (2015)  2 - p. e7-e7a , 2015
 
1-15